site stats

Kiniksa pharmaceuticals stock

WebKiniksa Pharmaceuticals, Ltd. (KNSA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong … Web23 uur geleden · Price To Cash Flow is a widely used stock evaluation measure. ... Kiniksa Pharmaceuticals, Ltd. (KNSA) Beats Q4 Earnings and Revenue Estimates 02/28/23 …

Kiniksa Pharmaceuticals (KNSA) stock Forecast for 2024 – 2026

WebThe 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price … Web23 uur geleden · Price To Cash Flow is a widely used stock evaluation measure. ... Kiniksa Pharmaceuticals, Ltd. (KNSA) Beats Q4 Earnings and Revenue Estimates 02/28/23-10:25AM EST Zacks. david culbertson rome ny https://i2inspire.org

Kiniksa Pharmaceuticals (KNSA) Stock Price & Analysis

Web6 jan. 2024 · In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Buy rating on Kiniksa Pharmaceuticals (KNSA – Research Report), with a price target of $20.00. The company's shares closed last Thursday at $11.10. According to TipRanks.com, Bayko is a 4-star analyst with an average return of 9.1% and a 45.4% success rate. WebKiniksa Pharmaceuticals, Ltd. (KNSA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. Zacks. WebKiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Portfolio Execution – ARCALYST® (rilonacept) Q4 2024 and full-year 2024 … gas mach number calculator

Kiniksa Pharmaceuticals, Ltd. (KNSA) stock price, news, quote

Category:Kiniksa Pharmaceuticals, Ltd. (KNSA) - Stock Analysis

Tags:Kiniksa pharmaceuticals stock

Kiniksa pharmaceuticals stock

Ensign Peak Advisors Inc Has $998,000 Stock Position in Kiniksa ...

Web13 apr. 2024 · Allspring Global Investments Holdings LLC lifted its holdings in shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA - Get Rating) by 890.6% during the 4th … Web31 mrt. 2024 · Kiniksa Pharmaceuticals Stock Snapshot 10.76 Bid 6,800.00 Bid Size 10.77 Ask 100.00 Ask Size 3/31/2024 Date 8:00 PM Time 399,027.00 Volume 10.70 Prev. Close 10.76 Open 775.32 M Market …

Kiniksa pharmaceuticals stock

Did you know?

Web23 uur geleden · Price To Free Cash Flow is a widely used stock evaluation measure. ... Kiniksa Pharmaceuticals, Ltd. (KNSA) Beats Q4 Earnings and Revenue Estimates 02/28/23-10:25AM EST Zacks. Web13 apr. 2024 · Allspring Global Investments Holdings LLC lifted its holdings in shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Rating) by 890.6% during the 4th quarter, according to its most recent ...

Web13 apr. 2024 · KNSA Kiniksa Pharmaceuticals, Ltd. Stock Price & Overview $10.80 0.09 ( +0.84%) 4:00 PM 04/10/23 NASDAQ $USD Post-Market: $10.80 4:01 PM Summary … WebKiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for …

Web30 mrt. 2024 · In contrast, the large caps rarely make big percentage-wise moves, possibly testing their stakeholders’ patience. For those who want to live a bit dangerously, these … Web28 feb. 2024 · Kiniksa Pharmaceuticals (UK), Ltd. Third Floor 23 Old Bond Street London, UK W1S 4PZ; US Headquarters Kiniksa Pharmaceuticals Corp. 100 Hayden Avenue …

WebKiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant...

Web13 jan. 2024 · The market capitalization of Kiniksa Pharmaceuticals is $686 522 000. At the same time, the number of shares in circulation is 34 275 000. The company's earnings before interest, taxes and depreciation for last year (called EBITDA) was -127 973 000$. The company has no profit and is unprofitable. gasmad sherbrookeWeb10 apr. 2024 · Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Price, Quote & News - Stock Analysis Kiniksa Pharmaceuticals, Ltd. ( KNSA) NASDAQ: KNSA · USD Add to … david culbreth minesWeb24 mrt. 2024 · Currently, Kiniksa Pharmaceuticals Ltd’s price-earnings ratio is 4.4. Kiniksa Pharmaceuticals Ltd’s trailing 12-month revenue is $220.2 million with a 83.3% profit … gas made from corn and sugarWebThe Wall Street analyst predicted. that Kiniksa Pharmaceuticals's share price could reach $20.00 by Mar 9, 2024. The average Kiniksa Pharmaceuticals stock price prediction … gas made out of cornWebKiniksa Pharmaceuticals (UK), Ltd. Third Floor 23 Old Bond Street London, UK W1S 4PZ; US Headquarters Kiniksa Pharmaceuticals Corp. 100 Hayden Avenue Lexington, MA … gas madison height miWeb5 apr. 2024 · Kiniksa Pharmaceuticals - KNSA Stock Forecast, Price & News $10.71 +0.27 (+2.59%) (As of 04/6/2024 12:00 AM ET) Compare Today's Range $10.29 $10.94 … gas made of carbon and hydrogenWebKiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for … gasly wins